Search Results

• • 2 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Preexisting memory CD[4.sup.+] T cells contribute to the primary response in an HIV-1 vaccine trial.

  Authors:Suzanne L. Campion, Elena Brenna, Elaine Thomson, Will Fischer, Kristin Ladell, James E. McLaren, et al.From:Journal of Clinical Investigation (Vol. 131, Issue 23) Peer-Reviewed

  Dec. 1, 20214,125 words Report 1400LNaive and memory CD[4.sup.+] T cells reactive with human immunodeficiency virus type 1 (HIV-1) are detectable in unexposed, unimmunized individuals. The contribution of preexisting CD[4.sup.+] T cells to a primary immune...

• Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.

  Authors:Kathryn E. Stephenson, Boris Julg, C. Sabrina Tan, Rebecca Zash, Stephen R. Walsh, Charlotte-Paige Rolle, et al.From:Nature Medicine (Vol. 27, Issue 10) Peer-Reviewed

  Oct. 202112,141 words Report 1620L

   Citation Only